1. Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy.
- Author
-
Mangone, Lucia, Marinelli, Francesco, Bisceglia, Isabella, Braghiroli, Maria Barbara, Banzi, Maria, Damato, Angela, Iori, Veronica, Pinto, Carmine, Cerullo, Loredana, Pellegri, Carlotta, Zizzo, Maurizio, Morabito, Fortunato, Neri, Antonino, and Giorgi Rossi, Paolo
- Subjects
RISK assessment ,CANCER relapse ,RESEARCH funding ,SURVIVAL rate ,CANCER patient medical care ,MULTIPLE regression analysis ,COLORECTAL cancer ,AGE distribution ,REPORTING of diseases ,DESCRIPTIVE statistics ,MULTIVARIATE analysis ,STATISTICS ,RESEARCH methodology ,TUMOR classification ,SURVIVAL analysis (Biometry) ,COMPARATIVE studies ,CONFIDENCE intervals ,PROGRESSION-free survival ,HEALTH care teams ,PROPORTIONAL hazards models - Abstract
Simple Summary: Colorectal cancer remains a prevalent neoplasm affecting both genders. Despite advancements in screening techniques facilitating early detection, effective patient management remains paramount. This study investigates the impact of a multidisciplinary team (MDT) approach on patient outcomes. Results reveal a significant improvement in survival rates among MDT-followed patients compared to those lacking MDT oversight. Notably, no-MDT patients exhibited a twofold increase in mortality risk from both colon and rectal cancers. Furthermore, advanced age (>70 years) and advanced-stage disease (III and IV) emerged as pivotal risk factors. Consequently, prioritizing MDT intervention for these high-risk cohorts is imperative to optimize therapeutic strategies. Colorectal cancer emerged as the third most prevalent malignancy worldwide, affecting nearly 2 million individuals in the year 2020. This study elucidates the pivotal role of a multidisciplinary team (MDT) in influencing the prognosis, as measured by relative survival rates, depending upon the stage and age. Cases recorded in an Italian Cancer Registry between 2017 and 2018 were included. Relative survival was reported at 1 and 3 years after diagnosis comparing MDT vs. no-MDT approaches. During the study period, 605 CRCs were recorded while 361 (59.7%) were taken care of by an MDT. Compared to no-MDT, MDT patients were younger with earlier stages and received more surgery. One year after diagnosis, survival was 78.7% (90% in MDT vs. 62% in no-MDT); stratifying by stage, in the MDT group there was no survival advantage for stage I (97.2% vs. 89.9%) and II (96.8% vs. 89.4%), but an advantage was observed for stage III (86.4% vs. 56.9%) and stage IV (63.7% vs. 27.4%). Similar values were observed at 3 years where a marked advantage was observed for stages III (69.9% vs. 35.1%) and IV (29.2% vs. 5.1%). The univariable analysis confirmed an excess risk in the no-MDT group (HR 2.6; 95% CI 2.0–3.3), also confirmed in the multivariable regression analysis (HR 2.0; 95% CI 1.5–2.5). Despite the increase in the number of MDT patients in 2018 (from 50% to 69%), this does not correspond to an improvement in outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF